Press Releases
- Switching to Remsima®▼ (infliximab) from originator has no negative effect on safety or efficacy in 10 real-world studies
- The Myriad myRisk Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer
- Senate Special Committee on Aging Examines Drug Pricing
- Joe Martinez to Join Center Point Clinical Services as Chief Executive Officer
- Joe Martinez to Join Center Point Clinical Services as Chief Executive Officer
- More Press Releases
Featured Jobs
> Need a job? Need to hire? Visit our jobs site.

